Carbon dots as theranostic agents / Madhuri Sharon and Ashmi Mewada.
By: Sharon, Madhuri [author.]
.
Material type: ![materialTypeLabel](/opac-tmpl/lib/famfamfam/BK.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
![](/opac-tmpl/bootstrap/images/filefind.png)
"Sales handles: - Biocompatible Carbon Dots as a suitable nanoparticle for health care Swarming Carbon dots can cross Blood Brain Barrier and deliver drugs for Neurodegenerative disease Conjugated/functionalized Carbon dots as tri-functional nano-worms for anti-cancer drug delivery, photothermal therapy and bioimaging Also discusses the suitability of Carbon Dots as payload for plant nutrient and drugs Market description: Scientists, researchers, clinicians, and biotechnologists working on theranostics; biomedical industrial sectors working on system biology, diagnostics, imaging, image-guided therapy employing state-of-the-art techniques; and PhD, master and under graduate level courses on therapeutics, biosensors, and translational medicine and personalized medicine"-- Provided by publisher.
Includes bibliographical references.
Print version record.
There are no comments for this item.